Variable Intensive Early Walking Post-Stroke - 2 (VIEWS-2)

NCT05727930 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-03-27

No results posted yet for this study

Summary

The proposed research will evaluate the individual and combined effects of task-specificity and intensity of rehabilitation interventions on locomotor function, community mobility and quality of life in patients with subacute (1-6 months) post-stroke.

Conditions

Interventions

BEHAVIORAL

High-intensity, task-specific (i.e., walking) interventions

Up to 30 1-hr sessions of training focused on walking trying to achieve higher cardiovascular intensities

BEHAVIORAL

High-intensity, non-specific physical therapy interventions

Up to 30 1-hr sessions of training focused on varied physical interventions trying to achieve higher cardiovascular intensities

BEHAVIORAL

Low-intensity, task-specific physical therapy interventions

Up to 30 1-hr sessions of training focused on walking trying to achieve lower cardiovascular intensities

BEHAVIORAL

Low-intensity, non-specific physical therapy interventions

Up to 30 1-hr sessions of training focused on varied physical interventions trying to achieve lower cardiovascular intensities

Sponsors & Collaborators

  • Northwestern University

    collaborator OTHER
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH
  • Indiana University

    lead OTHER

Principal Investigators

  • George Hornby · Indiana University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-11
Primary Completion
2028-10-15
Completion
2028-10-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05727930 on ClinicalTrials.gov